Department of Chemistry, One UTSA Circle, University of Texas San Antonio, San Antonio, TX 28249, USA.
J Chromatogr A. 2011 Sep 28;1218(39):7003-15. doi: 10.1016/j.chroma.2011.08.023. Epub 2011 Aug 16.
Transcription factor (TF) purification and identification is an important step in elucidating gene regulatory mechanisms. In this study, we present two new electrophoretic mobility shift assay (EMSA)-based multi-dimensional electrophoresis approaches to isolate and characterize TFs, using detection with either southwestern or western blotting and HPLC-nanoESI-MS/MS analysis for identification. These new techniques involve several major steps. First, EMSA is performed with agents that diminish non-specific DNA-binding and the DNA-protein complex is separated by native PAGE gel. The gel is then electrotransferred to PVDF membrane and visualized by autoradiography. Next, the DNA-protein complex, which has been transferred onto the blot, is extracted using a detergent-containing elution buffer. Following detergent removal, concentrated extract is separated by SDS-PAGE (EMSA-2DE), followed by in-gel trypsin digestion and HPLC-nanoESI-MS/MS analysis, or the concentrated extract is separated by two-dimensional gel electrophoresis (EMSA-3DE), followed by southwestern or western blot analysis to localize DNA binding proteins on blot which are further identified by on-blot trypsin digestion and HPLC-nanoESI-MS/MS analysis. Finally, the identified DNA binding proteins are further validated by EMSA-immunoblotting or EMSA antibody supershift assay. This approach is used to purify and identify GFP-C/EBP fusion protein from bacterial crude extract, as well as purifying AP1 and CEBP DNA binding proteins from a human embryonic kidney cell line (HEK293) nuclear extract. AP1 components, c-Jun, Jun-D, c-Fos, CREB, ATF1 and ATF2 were successfully identified from 1.5 mg of nuclear extract (equivalent to 3×10(7) HEK293 cells) with AP1 binding activity of 750 fmol. In conclusion, this new strategy of combining EMSA with additional dimensions of electrophoresis and using southwestern blotting for detection proves to be a valuable approach in the identification of transcriptional complexes by proteomic methods.
转录因子 (TF) 的纯化和鉴定是阐明基因调控机制的重要步骤。在本研究中,我们提出了两种新的电泳迁移率变动分析 (EMSA) 为基础的多维电泳方法,用于分离和鉴定 TF,使用西南印迹或 Western 印迹检测和 HPLC-nanoESI-MS/MS 分析进行鉴定。这些新技术涉及几个主要步骤。首先,进行 EMSA 实验,使用减少非特异性 DNA 结合的试剂,然后通过天然 PAGE 凝胶分离 DNA-蛋白质复合物。然后将凝胶电转移到 PVDF 膜上,并通过放射自显影进行可视化。接下来,将已转移到印迹上的 DNA-蛋白质复合物使用含去污剂的洗脱缓冲液提取。去污剂去除后,浓缩提取物通过 SDS-PAGE(EMSA-2DE)分离,然后进行胶内胰蛋白酶消化和 HPLC-nanoESI-MS/MS 分析,或浓缩提取物通过二维凝胶电泳(EMSA-3DE)分离,然后进行西南印迹或 Western 印迹分析,以定位印迹上的 DNA 结合蛋白,然后进一步通过印迹上的胰蛋白酶消化和 HPLC-nanoESI-MS/MS 分析进行鉴定。最后,通过 EMSA-免疫印迹或 EMSA 抗体超迁移实验进一步验证鉴定的 DNA 结合蛋白。该方法用于从细菌粗提物中纯化和鉴定 GFP-C/EBP 融合蛋白,以及从人胚肾细胞系 (HEK293) 核提取物中纯化 AP1 和 CEBP DNA 结合蛋白。从 1.5 毫克核提取物(相当于 3×10(7) HEK293 细胞)中成功鉴定了 AP1 成分 c-Jun、Jun-D、c-Fos、CREB、ATF1 和 ATF2,AP1 结合活性为 750 fmol。总之,这种将 EMSA 与电泳的其他维度相结合并使用西南印迹进行检测的新策略被证明是通过蛋白质组学方法鉴定转录复合物的一种有价值的方法。